Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmoteplase versus placebo in acute ischemic stroke
NL-OMON32542Phase 3Not yet recruiting
- Sponsor
- Lundbeck
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Desmoteplase 90 micrograms/kg with Placebo (2 arms). Primary endpoint: Modified Rankin Scale score at Day 90. Planned start Dec 2008; status: not yet recruiting.
02
Drugs
desmoteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON32542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32542.